JP2001502673A5 - - Google Patents

Download PDF

Info

Publication number
JP2001502673A5
JP2001502673A5 JP1998518106A JP51810698A JP2001502673A5 JP 2001502673 A5 JP2001502673 A5 JP 2001502673A5 JP 1998518106 A JP1998518106 A JP 1998518106A JP 51810698 A JP51810698 A JP 51810698A JP 2001502673 A5 JP2001502673 A5 JP 2001502673A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998518106A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001502673A (ja
Filing date
Publication date
Priority claimed from GBGB9621367.3A external-priority patent/GB9621367D0/en
Application filed filed Critical
Publication of JP2001502673A publication Critical patent/JP2001502673A/ja
Publication of JP2001502673A5 publication Critical patent/JP2001502673A5/ja
Ceased legal-status Critical Current

Links

JP10518106A 1996-10-14 1997-10-13 キラルペプチド核酸 Ceased JP2001502673A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9621367.3A GB9621367D0 (en) 1996-10-14 1996-10-14 Chiral peptide nucleic acids
GB9621367.3 1996-10-14
PCT/GB1997/002820 WO1998016550A1 (en) 1996-10-14 1997-10-13 Chiral peptide nucleic acids

Publications (2)

Publication Number Publication Date
JP2001502673A JP2001502673A (ja) 2001-02-27
JP2001502673A5 true JP2001502673A5 (enExample) 2005-06-16

Family

ID=10801375

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10518106A Ceased JP2001502673A (ja) 1996-10-14 1997-10-13 キラルペプチド核酸

Country Status (5)

Country Link
US (2) US6403763B1 (enExample)
EP (1) EP0956297A1 (enExample)
JP (1) JP2001502673A (enExample)
GB (1) GB9621367D0 (enExample)
WO (1) WO1998016550A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US9096636B2 (en) 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
GB9621367D0 (en) * 1996-10-14 1996-12-04 Isis Innovation Chiral peptide nucleic acids
US6326479B1 (en) * 1998-01-27 2001-12-04 Boston Probes, Inc. Synthetic polymers and methods, kits or compositions for modulating the solubility of same
JP2002537102A (ja) 1999-02-26 2002-11-05 カイロン コーポレイション 吸着された高分子および微粒子を有するミクロエマルジョン
JP2004514427A (ja) * 2000-11-24 2004-05-20 パンセコ・アクティーゼルスカブ Pna類似物
AU2002216946A1 (en) * 2001-01-05 2002-07-16 Pantheco A/S Modified pna molecules
US6716961B2 (en) * 2001-10-30 2004-04-06 Isis Innovation Limited Chiral peptide nucleic acids with a N-aminoethyl-d-proline backbone
EP1513871B1 (en) * 2002-02-04 2008-10-29 Isis Innovation Limited Pyrrolidinyl peptide nucleic acids
EP1560840B1 (en) * 2002-11-05 2015-05-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
EA009302B1 (ru) * 2003-05-20 2007-12-28 Инвестиген, Инк. Система обнаружения полинуклеотидов
US7790691B2 (en) 2003-06-20 2010-09-07 Isis Pharmaceuticals, Inc. Double stranded compositions comprising a 3′-endo modified strand for use in gene modulation
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
US8021839B2 (en) * 2006-02-24 2011-09-20 Investigen, Inc. Methods and compositions for detecting polynucleotides
US20080096193A1 (en) * 2006-10-24 2008-04-24 Charles Robert Bupp Methods and compositions for detecting polynucleotides
EP2099816A1 (en) * 2006-12-04 2009-09-16 Luminex Corporation Oxocarbonamide peptide nucleic acids and methods of using same
WO2008103702A2 (en) * 2007-02-23 2008-08-28 Investigen, Inc. Methods and compositions for rapid light-activated isolation and detection of analytes
US7964355B2 (en) * 2009-02-17 2011-06-21 Investigen, Inc. Assays based on detection of photobleaching reaction products from dye catalytic complex
US8785121B2 (en) 2010-07-08 2014-07-22 Bonac Corporation Single-stranded nucleic acid molecule for controlling gene expression
US8691782B2 (en) 2010-08-03 2014-04-08 Bonac Corporation Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
PT2674494E (pt) * 2010-08-03 2015-02-27 Bonac Corp Molécula de arn em cadeia simples com esqueleto licíclico contendo azoto
US9663784B2 (en) 2012-05-26 2017-05-30 Bonac Corporation Single-stranded nucleic acid molecule for regulating expression of gene having delivering function
EP3088524A4 (en) 2013-12-26 2017-08-09 Tokyo Medical University Artificial mimic mirna for controlling gene expression, and use of same
KR102357337B1 (ko) 2013-12-27 2022-01-28 가부시키가이샤 보낙 유전자 발현 제어를 위한 인공 매치형 miRNA 및 그 용도
SG11201705223XA (en) 2014-12-27 2017-07-28 Bonac Corp NATURALLY OCCURING miRNA FOR CONTROLLING GENE EXPRESSION, AND USE OF SAME
WO2016158809A1 (ja) 2015-03-27 2016-10-06 株式会社ボナック デリバリー機能と遺伝子発現制御能を有する一本鎖核酸分子

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA832762B (en) 1982-04-30 1983-12-28 Squibb & Sons Inc Substituted 4-phenoxy prolines
US4501901A (en) * 1983-09-19 1985-02-26 E. R. Squibb & Sons, Inc. Method for making substituted prolines
US5401901A (en) 1991-09-19 1995-03-28 W. L. Gore & Associates, Inc. Weather-resistant electromagnetic interference shielding for electronic equipment enclosures
DE4331011A1 (de) 1993-09-13 1995-03-16 Bayer Ag Nukleinsäuren-bindende Oligomere mit C-Verzweigung für Therapie und Diagnostik
DE4331012A1 (de) * 1993-09-13 1995-03-16 Bayer Ag Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik
GB9621367D0 (en) * 1996-10-14 1996-12-04 Isis Innovation Chiral peptide nucleic acids

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000501018A5 (enExample)
JP2000515763A5 (enExample)
JP2001513078A5 (enExample)
JP2000501324A5 (enExample)
JP2001504653A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2000500874A5 (enExample)
JP2000502425A5 (enExample)
JP2000502485A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2001505568A5 (enExample)
JP2000501876A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000500857A5 (enExample)
JP2001502673A5 (enExample)
JP2000502714A5 (enExample)
JP2000501569A5 (enExample)
JP2000502479A5 (enExample)